{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:53:45Z","timestamp":1792040025809,"version":"4.4.0"},"reference-count":79,"publisher":"Endocrinology Research Centre","issue":"1","license":[{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.probl-endojournals.ru\/jour\/about\/editorialPolicies#openAccessPolicy"}],"content-domain":{"domain":["www.probl-endojournals.ru"],"crossmark-restriction":true},"short-container-title":["Probl Endokrinol (Mosk)"],"DOI":"10.14341\/probl12660","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T10:00:25Z","timestamp":1613383225000},"page":"52-59","update-policy":"https:\/\/doi.org\/10.14341\/crossmarkpolicy2018","source":"Crossref","is-referenced-by-count":5,"title":["The role of glucose and insulin in the metabolic regulation of growth hormone secretion"],"prefix":"10.14341","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7006-0664","authenticated-orcid":true,"given":"E. L.","family":"Sorkina","sequence":"first","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6229-7274","authenticated-orcid":true,"given":"V. V.","family":"Chichkova","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7768-4717","authenticated-orcid":true,"given":"I. A.","family":"Sklyanik","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5057-127X","authenticated-orcid":true,"given":"M. V.","family":"Shestakova","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5634-7877","authenticated-orcid":true,"given":"G. A.","family":"Mel'nichenko","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5453-0248","authenticated-orcid":true,"given":"A.","family":"Barkan","sequence":"additional","affiliation":[{"name":"University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5458","published-online":{"date-parts":[[2021,2,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Frank SJ. Growth Hormone, Insulin-Like Growth Factor I, and Growth: Local Knowledge. Endocrinology. 2007;148(4):1486-1488. doi: https:\/\/doi.org\/10.1210\/en.2007-0064","DOI":"10.1210\/en.2007-0064"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Lichanska AM, Waters MJ. How growth hormone controls growth, obesity and sexual dimorphism. Trends Genet. 2008;24(1):41-47. doi: https:\/\/doi.org\/10.1016\/j.tig.2007.10.006","DOI":"10.1016\/j.tig.2007.10.006"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Raben MS, Hollenberg CH. Effect of growth hormone on plasma fatty acids. J Clin Invest. 1959;38(3):484-488. doi: https:\/\/doi.org\/10.1172\/JCI103824","DOI":"10.1172\/JCI103824"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"M\u00f8ller N, J\u00f8rgensen JOL, Alberti KGMM, et al. Short-Term Effects of Growth Hormone on Fuel Oxidation and Regional Substrate Metabolism in Normal Man. J Clin Endocrinol Metab. 1990;70(4):1179-1186. doi: https:\/\/doi.org\/10.1210\/jcem-70-4-1179","DOI":"10.1210\/jcem-70-4-1179"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Vorotnikova S, Pigarova E, Dzeranova L. Metabolicheskie effekty gormona rosta. Obesity and metabolism. 2011;8(4):55-59. (In Russ.). doi: https:\/\/doi.org\/10.14341\/2071-8713-5308","DOI":"10.14341\/2071-8713-5308"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Ranke MB, Wit JM. Growth hormone \u2014 past, present and future. Nat Rev Endocrinol. 2018;14(5):285-300. doi: https:\/\/doi.org\/10.1038\/nrendo.2018.22","DOI":"10.1038\/nrendo.2018.22"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Ocampo-Lim B. Nocturnal growth hormone (GH) secretion is eliminated by infusion of GH- releasing hormone antagonist. J Clin Endocrinol Metab. 1996;81(12):4396-4399. doi: https:\/\/doi.org\/10.1210\/jc.81.12.4396","DOI":"10.1210\/jc.81.12.4396"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Jaffe CA. Suppression of Growth Hormone (GH) Hypersecretion due to Ectopic GH-Releasing Hormone (GHRH) by a Selective GHRH Antagonist. J Clin Endocrinol Metab. 1997;82(2):634-637. doi: https:\/\/doi.org\/10.1210\/jc.82.2.634","DOI":"10.1210\/jc.82.2.634"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Goldenberg N, Barkan A. Factors Regulating Growth Hormone Secretion in Humans. Endocrinol Metab Clin North Am. 2007;36(1):37-55. doi: https:\/\/doi.org\/10.1016\/j.ecl.2006.11.003","DOI":"10.1016\/j.ecl.2006.11.003"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Dimaraki EV, Jaffe CA, Bowers CY, et al. Pulsatile and nocturnal growth hormone secretions in men do not require periodic declines of somatostatin. Am J Physiol Metab. 2003;285(1):E163-E170. doi: https:\/\/doi.org\/10.1152\/ajpendo.00334.2002","DOI":"10.1152\/ajpendo.00334.2002"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Jaffe CA. Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin--a clinical research center study. J Clin Endocrinol Metab. 1995;80(11):3321-3326. doi: https:\/\/doi.org\/10.1210\/jc.80.11.3321","DOI":"10.1210\/jc.80.11.3321"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Jaffe CA, DeMott-Friberg R, Barkan AL. Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli. J Clin Invest. 1996;97(4):934-940. doi: https:\/\/doi.org\/10.1172\/JCI118516","DOI":"10.1172\/JCI118516"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Pandya N. Growth Hormone (GH)-Releasing Peptide-6 Requires Endogenous Hypothalamic GH-Releasing Hormone for Maximal GH Stimulation. J Clin Endocrinol Metab. 1998;83(4):1186-1189. doi: https:\/\/doi.org\/10.1210\/jc.83.4.1186","DOI":"10.1210\/jc.83.4.1186"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Carreira MC, Crujeiras AB, Andrade S, et al. Ghrelin as a GH-Releasing Factor. Endocr Dev. 2013;25:49-58. doi: https:\/\/doi.org\/10.1159\/000346052","DOI":"10.1159\/000346052"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Bermann M, Jaffe CA, Tsai W, et al. Negative feedback regulation of pulsatile growth hormone secretion by insulin-like growth factor I. Involvement of hypothalamic somatostatin. J Clin Invest. 1994;94(1):138-145. doi: https:\/\/doi.org\/10.1172\/JCI117299","DOI":"10.1172\/JCI117299"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Carro E, Se\u00f1ar\u00eds RM, Seoane LM, et al. Role of Growth Hormone (GH)-Releasing Hormone and Somatostatin on Leptin-Induced GH Secretion. Neuroendocrinology. 1999;69(1):3-10. doi: https:\/\/doi.org\/10.1159\/000054397","DOI":"10.1159\/000054397"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-P\u00e9rez L, de Mirecki-Garrido M, Guerra B, et al. Sex steroids and growth hormone interactions. Endocrinol Nutr. 2016;63(4):171-180. doi: https:\/\/doi.org\/10.1016\/j.endoen.2016.04.006","DOI":"10.1016\/j.endoen.2016.04.006"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Birzniece V, Sata A, Ho KK. Growth hormone receptor modulators. Rev Endocr Metab Disord. 2009;10(2):145-156. doi: https:\/\/doi.org\/10.1007\/s11154-008-9089-x","DOI":"10.1007\/s11154-008-9089-x"},{"key":"ref19","unstructured":"Qiu H, Yang JK, Chen C. Influence of insulin on growth hormone secretion, level and growth hormone signalling. Sheng Li Xue Bao. 2017;69(5):541-556. doi: https:\/\/doi.org\/10.13294\/j.aps.2017.0062"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Kim S, Park M. Effects of growth hormone on glucose metabolism and insulin resistance in human. Ann Pediatr Endocrinol Metab. 2017;22(3):145-152. doi: https:\/\/doi.org\/10.6065\/apem.2017.22.3.145","DOI":"10.6065\/apem.2017.22.3.145"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Sakharova A, Horowitz J, Surya S, et al. Role of Growth Hormone in Regulating Lipolysis, Proteolysis, and Hepatic Glucose Production during Fasting. J Clin Endocrinol Metab. 2008;93(7):2755-2759. doi: https:\/\/doi.org\/10.1210\/jc.2008-0079","DOI":"10.1210\/jc.2008-0079"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Isgaard J, Carlsson L, Isaksson O, et al. Pulsatile Intravenous Growth Hormone (GH) Infusion to Hypophysectomized Rats Increases Insulin-Like Growth Factor I Messenger Ribonucleic Acid in Skeletal Tissues More Effectively than Continuous GH Infusion. Endocrinology. 1988;123(6):2605-2610. doi: https:\/\/doi.org\/10.1210\/endo-123-6-2605","DOI":"10.1210\/endo-123-6-2605"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Surya S, Horowitz J, Goldenberg N, et al. The Pattern of Growth Hormone Delivery to Peripheral Tissues Determines Insulin-Like Growth Factor-1 and Lipolytic Responses in Obese Subjects. J Clin Endocrinol Metab. 2009;94(8):2828-2834. doi: https:\/\/doi.org\/10.1210\/jc.2009-0638","DOI":"10.1210\/jc.2009-0638"},{"key":"ref24","unstructured":"Roth J, Glick SM, Yalow RS, et al. Secretion of human growth hormone: physiologic and experimental modification. Metabolism. 1963;12:577-579."},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Okada K, Suzuki N, Sugihara H, et al. Effects of hyper- and hypoglycemia on blood growth hormone level in free-feeding rats with anterolateral deafferentation of the medial basal hypothalamus. Brain Res. 1995;699(1):33-41. doi: https:\/\/doi.org\/10.1016\/0006-8993(95)00849-l","DOI":"10.1016\/0006-8993(95)00849-L"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Renier G, Serri O. Effects of acute and prolonged glucose excess on growth hormone release by cultured rat anterior pituitary cells. Neuroendocrinology. 1991;54(5):521-525. doi: https:\/\/doi.org\/10.1159\/000125947","DOI":"10.1159\/000125947"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Murao K, Sato M, Mizobuchi M, et al. Acute effects of hypoglycemia and hyperglycemia on hypothalamic growth hormone-releasing hormone and somatostatin gene expression in the rat. Endocrinology. 1994;134(1):418-423. doi: https:\/\/doi.org\/10.1210\/endo.134.1.7903934","DOI":"10.1210\/endo.134.1.7903934"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Giustina A. Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human. Endocr Rev. 1998;19(6):717-797. doi: https:\/\/doi.org\/10.1210\/er.19.6.717","DOI":"10.1210\/er.19.6.717"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Giustina A, Bresciani E, Tassi C, et al. Effect of pyridostigmine on the growth hormone response to growth hormone-releasing hormone in lean and obese type II Diabetic patients. Metabolism. 1994;43(7):893-898. doi: https:\/\/doi.org\/10.1016\/0026-0495(94)90273-9","DOI":"10.1016\/0026-0495(94)90273-9"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Kopelman PG, Mason AC, Noonan K, Monson JP. Growth hormone response to growth hormone releasing factor in diabetic men. Clin Endocrinol (Oxf). 1988;28(1):33-38. doi: https:\/\/doi.org\/10.1111\/j.1365-2265.1988.tb01200.x","DOI":"10.1111\/j.1365-2265.1988.tb01200.x"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Hayford J, Danney M, Hendrix J, et al. Integrated concentration of growth hormone in juvenile-onset diabetes. Diabetes. 1980;29(5):391-398. doi: https:\/\/doi.org\/10.2337\/diabetes.29.5.391","DOI":"10.2337\/diabetes.29.5.391"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Ismail I, Scanlon M, Peters J. Cholinergic control of growth hormone (GH) responses to GH-releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback. Clin Endocrinol (Oxf). 1993;38(2):149-157. doi: https:\/\/doi.org\/10.1111\/j.1365-2265.1993.tb00987.x","DOI":"10.1111\/j.1365-2265.1993.tb00987.x"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Patel YC, Wheatley T, Zingg HH. Increased blood somatostatin concentration in streptozotocin diabetic rats. Life Sci. 1980;27(17):1563-1570. doi: https:\/\/doi.org\/10.1016\/0024-3205(80)90565-2","DOI":"10.1016\/0024-3205(80)90565-2"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Ndon JA, Giustina A, Wehrenberg WB. Hypothalamic regulation of impaired growth hormone secretion in diabetic rats. 1. Studies in streptozotocin-induced diabetic rats. Neuroendocrinology. 1992;55(5):500-505. doi: https:\/\/doi.org\/10.1159\/000126163","DOI":"10.1159\/000126163"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Joanny P, Peyre G, Steinberg J, et al. Effect of diabetes on in vivo and in vitro hypothalamic somatostatin release. Neuroendocrinology. 1992;55(5):485-491. doi: https:\/\/doi.org\/10.1159\/000126161","DOI":"10.1159\/000126161"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Tannenbaum GS. Growth hormone secretory dynamics in streptozotocin diabetes: evidence of a role for endogenous circulating somatostatin. Endocrinology. 1981;108(1):76-82. doi: https:\/\/doi.org\/10.1210\/endo-108-1-76","DOI":"10.1210\/endo-108-1-76"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Olchovsky D, Bruno JF, Wood TL, et al. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor. Endocrinology. 1990;126(1):53-61. doi: https:\/\/doi.org\/10.1210\/endo-126-1-53","DOI":"10.1210\/endo-126-1-53"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Liu K, Paterson AJ, Konrad RJ, et al. Streptozotocin, an O-GlcNAcase inhibitor, blunts insulin and growth hormone secretion. Mol Cell Endocrinol. 2002;194(1-2):135-146. doi: https:\/\/doi.org\/10.1016\/s0303-7207(02)00155-7","DOI":"10.1016\/S0303-7207(02)00155-7"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"de Castro Barbosa T, Louren\u00e7o Poyares L, Fabres Machado U, et al. Chronic oral administration of arginine induces GH gene expression and insulin resistance. Life Sci. 2006;79(15):1444-1449. doi: https:\/\/doi.org\/10.1016\/j.lfs.2006.04.004","DOI":"10.1016\/j.lfs.2006.04.004"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Maccario M, Procopio M, Grottoli S, et al. Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity. Metabolism. 1996;45(3):342-346. doi: https:\/\/doi.org\/10.1016\/s0026-0495(96)90288-7","DOI":"10.1016\/S0026-0495(96)90288-7"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Casanueva FF, Villanueva L, Dieguez C, et al. Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary. J Clin Endocrinol Metab. 1987;65(4):634-642. doi: https:\/\/doi.org\/10.1210\/jcem-65-4-634","DOI":"10.1210\/jcem-65-4-634"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Ho PJ, Friberg RD, Barkan AL. Regulation of pulsatile growth hormone secretion by fasting in normal subjects and patients with acromegaly. J Clin Endocrinol Metab. 1992;75(3):812-819. doi: https:\/\/doi.org\/10.1210\/jcem.75.3.1517371","DOI":"10.1210\/jcem.75.3.1517371"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Arafat AM, M\u00f6hlig M, Weickert MO, et al. Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index. J Clin Endocrinol Metab. 2008;93(4):1254-1262. doi: https:\/\/doi.org\/10.1210\/jc.2007-2084","DOI":"10.1210\/jc.2007-2084"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Colao A, Pivonello R, Auriemma RS, et al. Growth hormone nadir during oral glucose load depends on waist circumference, gender and age: normative data in 231 healthy subjects. Clin Endocrinol (Oxf). 2011;74(2):234-240. doi: https:\/\/doi.org\/10.1111\/j.1365-2265.2010.03896.x","DOI":"10.1111\/j.1365-2265.2010.03896.x"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Iranmanesh A, Lizarralde G, Veldhuis JD. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab. 1991;73(5):1081-1088. doi: https:\/\/doi.org\/10.1210\/jcem-73-5-1081","DOI":"10.1210\/jcem-73-5-1081"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Williams T, Berelowitz M, Joffe SN, et al. Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. N Engl J Med. 1984;311(22):1403-1407. doi: https:\/\/doi.org\/10.1056\/NEJM198411293112203","DOI":"10.1056\/NEJM198411293112203"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Anderwald C-H, Tura A, Gessl A, et al. Whole-Body Insulin Sensitivity Rather than Body-Mass-Index Determines Fasting and Post-Glucose-Load Growth Hormone Concentrations. W\u00f6lfl S, ed. PLoS One. 2014;9(12):e115184. doi: https:\/\/doi.org\/10.1371\/journal.pone.0115184","DOI":"10.1371\/journal.pone.0115184"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Garmes HM, Castillo AR. Insulin signaling in the whole spectrum of GH deficiency. Arch Endocrinol Metab. 2019;63(6):582-591. doi: https:\/\/doi.org\/10.20945\/2359-3997000000188","DOI":"10.20945\/2359-3997000000188"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Cornford AS, Barkan AL, Hinko A, et al. Suppression in growth hormone during overeating ameliorates the increase in insulin resistance and cardiovascular disease risk. Am J Physiol Endocrinol Metab. 2012;303(10):E1264-E1272. doi: https:\/\/doi.org\/10.1152\/ajpendo.00320.2012","DOI":"10.1152\/ajpendo.00320.2012"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Hartman ML, Clayton PE, Johnson ML, et al. A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans. J Clin Invest. 1993;91(6):2453-2462. doi: https:\/\/doi.org\/10.1172\/JCI116480","DOI":"10.1172\/JCI116480"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Chapman IM, Hartman ML, Pieper KS, et al. Recovery of growth hormone release from suppression by exogenous insulin-like growth factor I (IGF-I): evidence for a suppressive action of free rather than bound IGF-I. J Clin Endocrinol Metab. 1998;83(8):2836-2842.","DOI":"10.1210\/jc.83.8.2836"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Chapman IM, Hartman ML, Pezzoli SS, et al. Effect of aging on the sensitivity of growth hormone secretion to insulin-like growth factor-I negative feedback. J Clin Endocrinol Metab. 1997;82(9):2996-3004. doi: https:\/\/doi.org\/10.1210\/jcem.82.9.4223","DOI":"10.1210\/jcem.82.9.4223"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Yamashita S, Melmed S. Insulin regulation of rat growth hormone gene transcription. J Clin Invest. 1986;78(4):1008-1014. doi: https:\/\/doi.org\/10.1172\/JCI112654","DOI":"10.1172\/JCI112654"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Yamashita S, Melmed S. Effects of insulin on rat anterior pituitary cells. Inhibition of growth hormone secretion and mRNA levels. Diabetes. 1986;35(4):440-447. doi: https:\/\/doi.org\/10.2337\/diab.35.4.440","DOI":"10.2337\/diab.35.4.440"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Prager D, Gebremedhin S, Melmed S. An insulin-induced DNA-binding protein for the human growth hormone gene. J Clin Invest. 1990;85(5):1680-1685. doi: https:\/\/doi.org\/10.1172\/JCI114620","DOI":"10.1172\/JCI114620"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Prager D, Melmed S. Insulin regulates expression of the human growth hormone gene in transfected cells. J Biol Chem. 1988;263(32):16580-16585. doi: https:\/\/doi.org\/10.1016\/S0021-9258(18)37429-5","DOI":"10.1016\/S0021-9258(18)37429-5"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Kim K, Lee J, Cho JH, Kim E-K. Insulin synthesized in the paraventricular nucleus of the hypothalamus regulates body length by modulating pituitary growth hormone production. IBRO Reports. 2019;6:S390. doi: https:\/\/doi.org\/10.1016\/j.ibror.2019.07.1239","DOI":"10.1016\/j.ibror.2019.07.1239"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Melmed S. Acromegaly. N Engl J Med. 2006;355(24):2558-2573. doi: https:\/\/doi.org\/10.1056\/NEJMra062453","DOI":"10.1056\/NEJMra062453"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Pl\u00f6ckinger U. Medical therapy of acromegaly. Int J Endocrinol. 2012;2012:268957. doi: https:\/\/doi.org\/10.1155\/2012\/268957","DOI":"10.1155\/2012\/268957"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Masuda A, Shibasaki T, Nakahara M, et al. The effect of glucose on growth hormone (GH)-releasing hormone-mediated GH secretion in man. J Clin Endocrinol Metab. 1985;60(3):523-526. doi: https:\/\/doi.org\/10.1210\/jcem-60-3-523","DOI":"10.1210\/jcem-60-3-523"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Broglio F, Benso A, Gottero C, et al. Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans. Clin Endocrinol (Oxf). 2002;57(2):265-271. doi: https:\/\/doi.org\/10.1046\/j.1365-2265.2002.01595.x","DOI":"10.1046\/j.1365-2265.2002.01595.x"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Pe\u00f1alva A, Burguera B, Casabiell X, et al. Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycemia on growth hormone (GH) releasing hormone-induced GH secretion in man: does acute hyperglycemia act through hypothalamic release of somatostatin?. Neuroendocrinology. 1989;49(5):551-554. doi: https:\/\/doi.org\/10.1159\/000125166","DOI":"10.1159\/000125166"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Nakagawa E, Nagaya N, Okumura H, et al. Hyperglycaemia suppresses the secretion of ghrelin, a novel growth-hormone-releasing peptide: responses to the intravenous and oral administration of glucose. Clin Sci (Lond). 2002;103(3):325-328. doi: https:\/\/doi.org\/10.1042\/cs1030325","DOI":"10.1042\/cs1030325"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"Pena-Bello L, Pertega-Diaz S, Outeiri\u00f1o-Blanco E, et al. Effect of Oral Glucose Administration on Rebound Growth Hormone Release in Normal and Obese Women: The Role of Adiposity, Insulin Sensitivity and Ghrelin. PLoS One. 2015;10(3):e0121087. doi: https:\/\/doi.org\/10.1371\/journal.pone.0121087","DOI":"10.1371\/journal.pone.0121087"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Hattori N, Shimatsu A, Kato Y, et al. Growth hormone responses to oral glucose loading measured by highly sensitive enzyme immunoassay in normal subjects and patients with glucose intolerance and acromegaly. J Clin Endocrinol Metab. 1990;70(3):771-776. doi: https:\/\/doi.org\/10.1210\/jcem-70-3-771","DOI":"10.1210\/jcem-70-3-771"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Grottoli S, Razzore P, Gaia D, et al. Three-hour spontaneous GH secretion profile is as reliable as oral glucose tolerance test for the diagnosis of acromegaly. J Endocrinol Invest. 2003;26(2):123-127. doi: https:\/\/doi.org\/10.1007\/BF03345139","DOI":"10.1007\/BF03345139"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Hage M, Kamenick\u00fd P, Chanson P. Growth Hormone Response to Oral Glucose Load: From Normal to Pathological Conditions. Neuroendocrinology. 2019;108(3):244-255. doi: https:\/\/doi.org\/10.1159\/000497214","DOI":"10.1159\/000497214"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Misra M, Cord J, Prabhakaran R, et al. Growth hormone suppression after an oral glucose load in children. J Clin Endocrinol Metab. 2007;92(12):4623-4629. doi: https:\/\/doi.org\/10.1210\/jc.2007-1244","DOI":"10.1210\/jc.2007-1244"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Costa AC, Rossi A, Martinelli CE Jr, et al. Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?. J Clin Endocrinol Metab. 2002;87(7):3142-3147. doi: https:\/\/doi.org\/10.1210\/jcem.87.7.8631","DOI":"10.1210\/jcem.87.7.8631"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"Russell-Aulet M, Jaffe CA, Demott-Friberg R, et al. In vivo semiquantification of hypothalamic growth hormone-releasing hormone (GHRH) output in humans: evidence for relative GHRH deficiency in aging. J Clin Endocrinol Metab. 1999;84(10):3490-3497. doi: https:\/\/doi.org\/10.1210\/jcem.84.10.6063","DOI":"10.1210\/jcem.84.10.6063"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"Verrua E, Filopanti M, Ronchi CL, et al. GH response to oral glucose tolerance test: a comparison between patients with acromegaly and other pituitary disorders. J Clin Endocrinol Metab. 2011;96(1):E83-E88. doi: https:\/\/doi.org\/10.1210\/jc.2010-1115","DOI":"10.1210\/jc.2010-1115"},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"Colao A, Amato G, Pedroncelli AM, et al. Gender- and age-related differences in the endocrine parameters of acromegaly. J Endocrinol Invest. 2002;25(6):532-538. doi: https:\/\/doi.org\/10.1007\/BF03345496","DOI":"10.1007\/BF03345496"},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"Weissberger AJ, Ho KK, Lazarus L. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab. 1991;72(2):374-381. doi: https:\/\/doi.org\/10.1210\/jcem-72-2-374","DOI":"10.1210\/jcem-72-2-374"},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"Freda PU, Landman RE, Sundeen RE, et al. Gender and age in the biochemical assessment of cure of acromegaly. Pituitary. 2001;4(3):163-171. doi: https:\/\/doi.org\/10.1023\/a:1015314906972","DOI":"10.1023\/A:1015314906972"},{"key":"ref75","doi-asserted-by":"crossref","unstructured":"Hansen BR, Haugaard SB, Iversen J, et al. Impact of switching antiretroviral therapy on lipodystrophy and other metabolic complications: a review. Scand J Infect Dis. 2004;36(4):244-253. doi: https:\/\/doi.org\/10.1080\/00365540410019381","DOI":"10.1080\/00365540410019381"},{"key":"ref76","doi-asserted-by":"crossref","unstructured":"Yalow RS, Goldsmith SJ, Berson SA. Influence of physiologic fluctuations in plasma growth hormone on glucose tolerance. Diabetes. 1969;18(6):402-408. doi: https:\/\/doi.org\/10.2337\/diab.18.6.402","DOI":"10.2337\/diab.18.6.402"},{"key":"ref77","doi-asserted-by":"crossref","unstructured":"Sandret L, Maison P, Chanson P. Place of cabergoline in acromegaly: a meta-analysis. J Clin Endocrinol Metab. 2011;96(5):1327-1335. doi: https:\/\/doi.org\/10.1210\/jc.2010-2443","DOI":"10.1210\/jc.2010-2443"},{"key":"ref78","doi-asserted-by":"crossref","unstructured":"Devesa J, Diaz MJ, Tresguerres JA, et al. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men. J Clin Endocrinol Metab. 1991;73(2):251-256. doi: https:\/\/doi.org\/10.1210\/jcem-73-2-251","DOI":"10.1210\/jcem-73-2-251"},{"key":"ref79","doi-asserted-by":"crossref","unstructured":"Low LCK. Growth Hormone-Releasing Hormone: Clinical Studies and Therapeutic Aspects. Seoane LM, ed. Neuroendocrinology. 1991;53(1):37-40. doi: https:\/\/doi.org\/10.1159\/000125793","DOI":"10.1159\/000125793"}],"container-title":["Problems of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.probl-endojournals.ru\/jour\/article\/viewFile\/12660\/9893","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T10:00:31Z","timestamp":1613383231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.probl-endojournals.ru\/jour\/article\/view\/12660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,12]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,2,12]]}},"URL":"https:\/\/doi.org\/10.14341\/probl12660","relation":{},"ISSN":["2308-1430","0375-9660"],"issn-type":[{"value":"2308-1430","type":"electronic"},{"value":"0375-9660","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,12]]}}}